Type of Cancer
Solid Tumor
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.